Cardiac Resynchronization Therapy in Heart Failure

Cardiac resynchronization therapy (CRT) is a device-based treatment for patients with advanced heart failure and ventricular dyssynchrony. It improves heart efficiency, symptoms, and survival.

Key Highlights:

  • Indications: Patients with reduced ejection fraction, widened QRS complex, and persistent symptoms despite optimal medical therapy.
  • Mechanism: CRT coordinates contraction of the left and right ventricles to improve cardiac output.
  • Clinical benefits: Reduces hospitalization, improves exercise tolerance, and enhances quality of life.
  • Device monitoring: Remote follow-up ensures optimal pacing and detects complications early.
  • Future developments: Integration with AI allows predictive modeling for therapy response.

CRT remains a cornerstone therapy for select heart failure patients, combining mechanical support with advanced monitoring technologies.

    Related Conference of Cardiac Resynchronization Therapy in Heart Failure

    October 06-07, 2025

    6th International Conference on Physics

    Paris, France
    December 01-02, 2025

    9th International Meeting on Fluid Dynamics & Fluid Mechanics

    Vancouver, Canada
    December 15-16, 2025

    13th World Congress on Physical and Theoretical Chemistry

    Amsterdam, Netherlands
    February 09-10, 2026

    9th World Congress On Cardiology and Heart Failure

    London, UK
    February 19-20, 2026

    4th World Congress on Quantum Physics

    Paris, France

    Cardiac Resynchronization Therapy in Heart Failure Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in